Repositorio Digital de la UPF
Publication
Artículo científico (JournalArticle)
Associations between light at night and mental health: A systematic review and meta-analysis
Light at night (LAN) disrupts the circadian rhythm by altering the natural light-dark cycle. With increasing interest in the relationship between LAN and mental health, there is value in an updated systematic review and meta-analysis considering prominent mental health conditions that also critically appraises LAN exposure assessment. We conducted a systematic review of six databases, two registries, and Google Scholar to identify studies examining the associations between indoor and outdoor LAN exposure (high vs. low exposure) and mental health outcomes (depression, bipolar disorder, anxiety, and schizophrenia), completing inverse-variance random-effects meta-analyses. Nineteen studies with a total population of 556,861 were included in the review. LAN exposure was associated with increased odds of depression prevalence (odds ratio [OR]: 1.18; 95 % confidence interval [CI]: 1.09 to 1.28), with stronger associations for bedside (OR: 1.45; 95 % CI: 1.03 to 2.04) or wrist-measured indoor LAN (OR: 1.30; 95 % CI: 1.22 to 1.38) than satellite-measured outdoor LAN exposure (OR: 1.10; 95 % CI: 1.04 to 1.17) and in older adults (OR: 1.56; 95 % CI: 1.24 to 1.96) compared to general adults (OR: 1.16; 95 % CI: 1.06 to 1.28) or youth (OR: 1.07; 95 % CI: 0.99 to 1.16). LAN exposure was also associated with an increased prevalence of bipolar disorder (OR: 1.19; 95 % CI: 1.08 to 1.31) and anxiety (OR: 1.10; 95 % CI: 1.02 to 1.20) and increased incidence of anxiety (hazard ratio [HR]: 1.08; 95 % CI: 1.02 to 1.15) and schizophrenia (HR: 1.55; 95 % CI: 1.01 to 2.39); however, the incidence of depression did not achieve statistical significance (HR: 1.53; 95 % CI: 0.98 to 2.38). Overall, our results suggest that LAN exposure influences adverse mental health conditions, with differences in results appreciated for depression prevalence depending on how LAN exposure was measured. Additional research is needed on the effects of LAN given its undoubted interest in the prevention and treatment of mental disorders., AD received summer studentship awards from Alberta Innovates and the Northern Alberta Clinical Trials and Research Centre. JFN and AA were supported by the Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033; grant PID2020-117767GB-I00). JFN is supported by CTS195 group (Junta de Andalucia, Spain) and AA is supported by the Generalitat de Catalunya (2021SGR801). BNH has
received funding from the Instituto de Salud Carlos III (ISCIII) and the European Union NextGenerationEU/PRTR (Grant IHMC22/00017). PL received funding from Synergy Respiratory and Cardiac Care, Alberta, Canada and AstraZeneca Canada; she reports personal fees from AstraZeneca Canada and GSK Canada, outside the submitted work. RM and HD received funding from Asthma and Lung UK WAPG22/100005. HD additionally received funding from MRC-CSF-MR/V029460/1. AP-C was supported by the MINECO (Ministry of Economy in Spain) Grant no. PRE2019-089038, fellowship. ISGlobal acknowledges support from the Spanish Ministry of cience and Innovation through the -Centro de Excelencia Severo Ochoa 2019-2023- Program (CEX2018-000806-S) and support from the Generalitat de Catalunya through the CERCA Program. SM reports personal fees rom Elsevier Inc. (USA), Synergy Respiratory and Cardiac Care (Canada), and Permanyer Inc. (Spain); he reports lecture fees from Apollo Gleneagles Hospital (India) and the Institute of Allergy, Kolkata (India), outside the submitted work. Study supporters were not involved in the study design; the collection, analysis, and interpretation of data; writing of the manuscript; or the decision to submit the manuscript for publication.
Project:
ES / 2PE PID2020-117767GB-I00